4.6 Article

Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study

期刊

SURGERY
卷 165, 期 3, 页码 516-524

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2018.08.031

关键词

-

类别

资金

  1. National Natural Science Foundation of China [81472284, 81672699]
  2. Shanghai Distinguished Young Medical Talents Program
  3. Shanghai Pujiang Program [169D004]

向作者/读者索取更多资源

Background: There is a striking sex difference in the incidence of hepatocellular carcinoma, with a strong predominance for men; however, the impact of sex on the incidence of recurrence after curative resection of hepatocellular carcinoma remains controversial. This study aimed to assess sex differences in the risks of recurrence and mortality for patients treated with curative resection of hepatocellular carcinoma. Methods: We retrospectively reviewed data from 1,435 hepatocellular carcinoma patients treated with curative resection (1,228 men and 207 women) between 2004 and 2014 at 5 institutions in China. Patients' baseline characteristics, operative variables, and rates of early recurrence (<= 2 years after resection), late recurrence (>2 years after resection), and cancer-specific mortality were evaluated and compared. To clarify the true oncologic impact of sex, multivariable competing-risks regression analyses were performed to identify predictors associated with early and late recurrence, as well as cancer-specific mortality. Results: The early recurrence rates between men and women were similar (43.3% vs 42.0%, P = .728), but the late recurrence and rates of cancer-specific mortality in men were greater compared with women (17.2% vs 11.2%, P = .044; and 42.8% vs 34.3%, P = .022, respectively). Multivariable competing-risks regression analyses revealed no sex difference in early recurrence; however, men had greater late recurrence rate (hazard ratio, 1.752; 95% confidence interval, 1.145-2.682; P = .010) and rate of cancer-specific mortality (hazard ratio, 1.307; 95% confidence interval, 1.015-1.683; P = .038). Conclusion: There was no difference in early recurrence rate (<= 2 years after resection between men and women, but men had significantly greater late recurrence (>2 years) and rates of cancer-specific mortality after hepatocellular carcinoma resection than women. (C) 2018 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis

Hao Xing, Li-Yang Sun, Wen-Tao Yan, Bing Quan, Lei Liang, Chao Li, Ya-Hao Zhou, Hong Wang, Jian-Hong Zhong, Wei-Min Gu, Ting-Hao Chen, Ming-Da Wang, Han Wu, Timothy M. Pawlik, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang

Summary: The study showed that patients who underwent repeat hepatectomy for early recurrence of hepatocellular carcinoma had worse overall survival and disease-free survival compared to those with late recurrence. These findings can provide guidance for physicians in selecting patients for repeat hepatectomy.

SURGERY (2021)

Article Surgery

Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: A multicenter study from a HBV-endemic area

Ju-Dong Li, Yong-Kang Diao, Jie Li, Han Wu, Li-Yang Sun, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yong-Yi Zeng, Ya-Hao Zhou, Yu Wang, Yao-Ming Zhang, Ying-Jian Liang, Wan Yee Lau, Chao Li, Lei Liang, Ming-Da Wang, Cheng-Wu Zhang, Feng Shen, Cheng-Hao Shao, Tian Yang

Summary: The study found that preoperative prealbumin level was associated with postoperative mortality and morbidity for patients undergoing hepatic resection for HCC, with the low prealbumin group showing higher rates of adverse events. Prealbumin level could serve as an important predictor for postoperative outcomes in these patients.

AMERICAN JOURNAL OF SURGERY (2021)

Editorial Material Medicine, Research & Experimental

Clinical utility of serum biomarkers for hepatocellular carcinoma

Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Yee Lau, Tian Yang

BIOMARKERS IN MEDICINE (2021)

Review Chemistry, Multidisciplinary

Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management

Han Wu, Ming-Da Wang, Lei Liang, Hao Xing, Cheng-Wu Zhang, Feng Shen, Dong-Sheng Huang, Tian Yang

Summary: Nanotechnology has gained extensive attention in surveillance, imaging, and treatment of hepatocellular carcinoma. Nanomedicines focus on early diagnosis and precise treatment of HCC, offering promising potential applications in future clinical practice.
Article Surgery

Long-term oncologic outcomes of liver resection for hepatocellular carcinoma in adolescents and young adults: A multicenter study from a hepatitis B virus-endemic area

Yong-Kang Diao, Jun-Wei Liu, Han Wu, Ming-Da Wang, Xin-Ping Fan, Ting-Hao Chen, Jian-Yu Wang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Jie Li, Ying-Jian Liang, Zhi-Yu Chen, Wan Yee Lau, Lei Liang, Chao Li, Cheng-Wu Zhang, Feng Shen, Dong-Sheng Huang, Tian Yang

Summary: Adolescents and young adults (AYAs) in areas with endemic hepatitis B virus infection are more likely to develop hepatocellular carcinoma (HCC). After undergoing HCC resection, AYAs have a higher risk of recurrence than older adults, indicating a need for enhanced surveillance for postoperative recurrence among AYAs.

AMERICAN JOURNAL OF SURGERY (2021)

Article Gastroenterology & Hepatology

Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study

Lei Liang, Bing Quan, Han Wu, Yong-Kang Diao, Jie Li, Ting-Hao Chen, Yao-Ming Zhang, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Matteo Serenari, Matteo Cescon, Myron Schwartz, Yong-Yi Zeng, Ying-Jian Liang, Hang-Dong Jia, Hao Xing, Chao Li, Ming-Da Wang, Wen-Tao Yan, Wan-Yuan Chen, Wan Yee Lau, Cheng-Wu Zhang, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Tian Yang

Summary: An individualized patient-specific tool was developed and validated to predict the benefit of surgery for hepatocellular carcinoma (HCC) patients. The tool showed good performance in identifying patients at highest risk of death within 6 months of surgery, which may help guide surgical decision-making to avoid futile surgery.

HEPATOLOGY INTERNATIONAL (2021)

Article Oncology

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)

Lei Liang, Ming-Da Wang, Yao-Ming Zhang, Wan-Guang Zhang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Timothy M. Pawlik, Dong-Sheng Huang, Tian Yang

Summary: This study investigated long-term recurrence and survival after hepatectomy for high-AFP HCC, finding that postoperative incomplete biomarker response was the strongest risk factor for predicting poor overall survival and recurrence-free survival in these patients.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Letter Gastroenterology & Hepatology

Letter: association of laboratory indexes and magnetic resonance elastography-associated liver stiffness with complications and mortality

Li-Yang Sun, Hang-Dong Jia, Lei Liang, Dong-Sheng Huang, Tian Yang

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Oncology

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Lan-Qing Yao, Zhen-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang

Summary: This study investigates the clinical features and long-term prognosis of patients with hepatocellular carcinoma (HCC) who experienced recurrence after curative hepatic resection. The results show that nearly half of the patients experienced recurrence, and several factors such as cirrhosis, preoperative alpha-fetoprotein level, and tumor size are associated with postoperative recurrence. Treatment modalities and regular surveillance after recurrence can significantly impact patient survival.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis

Zheng-Liang Chen, Lan-Qing Yao, Jia-Le Pu, Han Wu, Xin-Fei Xu, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Zhi-Yu Chen, Li-Yang Sun, Yong-Kang Diao, Jian-Hong Zhong, Wan Yee Lau, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Ying-Jian Liang, Tian Yang

Summary: This study compared the outcomes of partial hepatectomy in patients with HCC and CSPH with or without concurrent CSED. The results showed that patients who underwent CSED had better overall survival and lower rate of variceal bleeding compared to those without CSED.
Editorial Material Oncology

ASO Visual Abstract: Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Lan-Qing Yao, Zhen-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang

ANNALS OF SURGICAL ONCOLOGY (2022)

Correction Oncology

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis (Feb, 10.1245/s10434-022-11454-y, 2022

Lan-Qing Yao, Zheng-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang

ANNALS OF SURGICAL ONCOLOGY (2022)

Review Pharmacology & Pharmacy

Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine

Han Wu, Ming-Da Wang, Jia-Qi Zhu, Zhen-Li Li, Wan-Yin Wang, Li-Hui Gu, Feng Shen, Tian Yang

Summary: Liver cancer is the seventh-most-common cancer worldwide and the fourth-leading cause of cancer mortality. Mesoporous nanoparticles have been developed as specific carriers for drugs and imaging agents in the diagnosis and treatment of liver cancer. The design of mesoporous nanoparticles has greatly improved their drug-loading efficiency, biocompatibility, and biodegradability. This review summarizes the advanced designs of mesoporous nanoparticles in the different diagnostic and therapeutic fields of liver cancer and discusses their advantages and disadvantages in application.

PHARMACEUTICS (2022)

Article Gastroenterology & Hepatology

Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis

Xin-Fei Xu, Han Wu, Ju-Dong Li, Lan-Qing Yao, Bin Huang, Yong-Kang Diao, Ting-Hao Chen, Wei-Min Gu, Zhong Chen, Jie Li, Yao-Ming Zhang, Hong Wang, Ying-Jian Liang, Ya-Hao Zhou, Chao Li, Ming-Da Wang, Cheng-Wu Zhang, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang

Summary: This study found that the prognosis of solitary huge hepatocellular carcinoma (HCC) is associated with tumor morphology, with patients having balloon-shaped HCC (BS-HCC) showing better long-term survival after liver resection. This finding helps guide the treatment strategy for patients with solitary huge HCC.

HEPATOBILIARY SURGERY AND NUTRITION (2023)

Article Gastroenterology & Hepatology

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study

Wen-Tao Yan, Chao Li, Lan-Qing Yao, Hai-Bo Qiu, Ming-Da Wang, Xin-Fei Xu, Ya-Hao Zhou, Hong Wang, Ting-Hao Chen, Wei-Min Gu, Jian-Hong Zhong, Han Wu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang

Summary: This study identified predictors and long-term prognosis of early and late recurrence after hepatic resection for hepatocellular carcinoma (HCC). Results showed that there were different independent predictors associated with early and late recurrence, with patients experiencing early recurrence having poorer long-term survival compared to those with late recurrence.

HEPATOBILIARY SURGERY AND NUTRITION (2021)

暂无数据